These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 15377554)
1. Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies. Hamacher T; Schinzel M; Schölzel-Klatt A; Neff HM; Maier H; Schlaffer G; Beausencourt E; Jütte M; Scholz R; Lorger C; Stewart WC Br J Ophthalmol; 2004 Oct; 88(10):1295-8. PubMed ID: 15377554 [TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies. Konstas AG; Bányai L; Blask KD; Väth J; Kozobolis VP; Trüb PR; Tsironi S; Maloutas S; Teus MA; Stewart WC J Ocul Pharmacol Ther; 2004 Oct; 20(5):375-82. PubMed ID: 15650512 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy. Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN Eye (Lond); 2004 Oct; 18(10):990-5. PubMed ID: 15037890 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure. Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480 [TBL] [Abstract][Full Text] [Related]
5. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy. Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549 [TBL] [Abstract][Full Text] [Related]
6. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Cvenkel B; Stewart JA; Nelson LA; Stewart WC Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension. Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402 [TBL] [Abstract][Full Text] [Related]
8. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448 [TBL] [Abstract][Full Text] [Related]
9. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111 [TBL] [Abstract][Full Text] [Related]
10. Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy. Varma R; Hwang LJ; Grunden JW; Bean GW Br J Ophthalmol; 2010 Jan; 94(1):80-4. PubMed ID: 19692375 [TBL] [Abstract][Full Text] [Related]
11. Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies. Bayer A; Weiler W; Oeverhaus U; Skrotzki FE; Stewart WC; J Ocul Pharmacol Ther; 2004 Dec; 20(6):470-8. PubMed ID: 15684807 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study. Chiseliţă D; Antohi I; Medvichi R; Danielescu C Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674 [TBL] [Abstract][Full Text] [Related]
13. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial. Hatanaka M; Reis A; Sano ME; Susanna R J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119 [TBL] [Abstract][Full Text] [Related]
14. Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%. Konstas AG; Kozobolis VP; Lallos N; Christodoulakis E; Stewart JA; Stewart WC Eye (Lond); 2004 Dec; 18(12):1264-9. PubMed ID: 15218522 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension. Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251 [TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Konstas AG; Kozobolis VP; Tersis I; Leech J; Stewart WC Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169 [TBL] [Abstract][Full Text] [Related]
17. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination. Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049 [TBL] [Abstract][Full Text] [Related]
18. Latanoprost : an update of its use in glaucoma and ocular hypertension. Perry CM; McGavin JK; Culy CR; Ibbotson T Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627 [TBL] [Abstract][Full Text] [Related]
19. The Efficacy of a Latanoprost/Timolol Fixed Combination Versus Latanoprost and Timolol Gel-forming Solution Unfixed Combination on Daytime Intraocular Pressure. Özyol E; Özyol P J Glaucoma; 2016 Feb; 25(2):135-9. PubMed ID: 25264990 [TBL] [Abstract][Full Text] [Related]
20. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost. Tamer C; Oksüz H Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]